Spectrum Pharmaceuticals, Inc. Elects Two New Healthcare Industry Veterans to the Board of Directors

Published: Jul 01, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Spectrum Pharmaceuticals (NasdaqGS:SPPI), a biotechnology company with fully-integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the appointment of Dolatrai Vyas, Ph.D. and Raymond Cohen to its board of directors at the Annual Meeting of Stockholders held on June 28, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news